IP Library Granted Patent US 7,964,074
Granted Patent B1
US 7,964,074 · App. 12/391,405 · Granted Jun 21, 2011

Electroelution of oligonucleotides from gel matrices

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,964,074
App. No.
12/391,405
Granted
Jun 21, 2011
Kind
B1
Abstract

The invention can be used to purify and extract a target oligonucleotide from a gel substrate. The current invention extracts the target oligonucleotide so quickly that burn-off against the positive electrode is greatly reduced, yielding high optical density and purity. The need for an osmotic membrane or heavy salt/light salt barrier to capture the oligonucleotide is eliminated. The invention does not require a high salt concentration and therefore does not require a desalting column that is time-consuming and reduces yield.

Claims (21)

1. An apparatus for the recovery of a target oligonucleotide in a gel sample, said apparatus comprising:

a) a chamber for placement of the gel sample and a buffer solution;

b) a source of electric current to provide a negative electric current to the chamber;

c) a recovery well separate from the chamber wherein the gel sample forms a bottom of the recovery well, said recovery well capable of holding a buffer solution; and

d) a second source of electric current to provide a positive electric current to the recovery well.

2. An apparatus of claim 1 wherein the apparatus contains more than one chamber and more than one recovery well.

3. An apparatus of claim 1 further comprising a recovery well aspirator.

4. An automated system for the loading and elution of a gel, comprising:

a) a component for the loading of a sample into a gel;

b) a component for the transfer of the gel to the apparatus of claim 1 ; and

c) an aspirator.

5. The automated system of claim 4 wherein the apparatus of claim 1 has more than one chamber and more than one recovery well.

6. A method of removing a nucleic acid sample from a gel, the method comprising:

a) excising a gel portion from the gel, said gel portion containing the nucleic acid sample;

b) providing a negative charge to the gel portion;

c) providing a recovery well, said recovery well being formed by the placement of a surface with an opening, wherein said opening sets against the gel portion and forms a seal to allow a buffer solution to sit in the opening against the gel portion;

d) providing a buffer solution to the opening;

e) providing a positive charge to the buffer solution; and

f) collecting the buffer solution.

7. The method of claim 6 wherein the negative charge and the positive charge are provided for about 90 seconds.

8. The method of claim 6 wherein a current provided by the positive and negative charges is greater than 100 volts.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Oct 5, 2017
From: JPMORGAN CHASE BANK, N.A.
To: INTEGRATED DNA TECHNOLOGIES, INC.
Reel/Frame 043800/0186 →
SECURITY AGREEMENT Recorded Apr 26, 2010
From: INTEGRATED DNA TECHNOLOGIES, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 024286/0152 →
SECURITY AGREEMENT Recorded Jun 18, 2009
From: INTEGRATED DNA TECHNOLOGIES, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 022846/0023 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2009
From: SEXTON, JOSEPH P.
To: INTEGRATED DNA TECHNOLOGIES, INC.
Reel/Frame 022338/0561 →